Company / Free Cash Flow per Share
Seres Therapeutics, Inc. Free Cash Flow per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$14.49
FY2025
5-year range
-$14.49 / -$0.02
FY2021-FY2025
Trend
-62939.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -62940% YoY in FY2025, a notable deviation from the 9-year average annual change of -7037%.
Based on SEC 10-K filings.
-14.49 in FY2025.
Declined from $-1.03 to $-14.49 over the past 3 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 62939.8% year-over-year.
- Peak free cash flow per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$14.49 | -62939.8% |
| FY2023 | -$0.02 | +97.8% |
| FY2022 | -$1.03 | -20.9% |
| FY2021 | -$0.85 | +8.2% |
| FY2020 | -$0.92 | +52.9% |
| FY2019 | -$1.96 | -454.4% |
| FY2018 | $0.55 | +149.4% |
| FY2017 | -$1.12 | -285.4% |
| FY2016 | -$0.29 | +63.6% |
| FY2015 | -$0.80 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026